Inventor · disambiguated record
Gregg S. Warshaw
Also filed as: WARSHAW GREGG · WARSHAW GREGG S
7 granted patents·2 pending applications·23 citations·filing 2015–2024
81Inventor score
Technology areasC12N
Files withREGENERON PHARMA9
Top patents by PatentIndex Score
9 records- 0195US9738897B2Nuclease-mediated DNA assemblyREGENERON PHARMA·Filed 2015·Granted Aug 22, 2017·13 cites·29 claims
- 0293US9580715B2Nuclease-mediated DNA assemblyREGENERON PHARMA·Filed 2015·Granted Feb 28, 2017·7 cites·30 claims
- 0387US2024229048A1Nuclease-mediated dna assemblyREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0483US10626402B2Nuclease-mediated DNA assemblyREGENERON PHARMA·Filed 2019·Granted Apr 21, 2020·1 cites·52 claims
- 0582US10273488B2Nuclease-mediated DNA assemblyREGENERON PHARMA·Filed 2017·Granted Apr 30, 2019·1 cites·31 claims
- 0681US11111504B2Methods for scarless introduction of targeted modifications into targeting vectorsREGENERON PHARMA·Filed 2020·Granted Sep 7, 2021·1 cites·29 claims
- 0771US11932859B2Nuclease-mediated DNA assemblyREGENERON PHARMA·Filed 2020·Granted Mar 19, 2024·0 cites·31 claims
- 0864US11499164B2Methods for scarless introduction of targeted modifications into targeting vectorsREGENERON PHARMA·Filed 2021·Granted Nov 15, 2022·0 cites·29 claims
- 0962US2025332287A1Identification of tissue-specific extragenic safe harbors for gene therapy approachesREGENERON PHARMA·Filed 2023·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →